Published in OBGYN and Reproduction Week, April 18th, 2005
V. Jayagopal and colleagues, University of Hull, North Humberside, U.K., evaluated and compared "the effect of treatment with orlistat vs. metformin on the hormonal and biochemical features of patients with polycystic ovarian syndrome (PCOS)."
According to their report, "Twenty-one Caucasian women with PCOS [mean(±SEM) age 27±0.9 years and body mass index 36.7±3.3 kg/m2] participated in this prospective, randomized, open-labeled study. All subjects had an 8-week run-in period...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.